Advertisement

Tumor Biology

, Volume 37, Issue 12, pp 15467–15476 | Cite as

Regulation of autophagy by Ca2+

Open Access
Review

Abstract

Autophagy is an evolutionarily conserved lysosomal catabolic process used as an internal engine in response to nutrient starvation or metabolic stress. A number of protein complexes and an intricate network of stress signaling cascades impinge on the regulation of autophagy; the mammalian target of rapamycin serves as a canonical player. Ca2+, as a major intracellular second messenger, regulates multiple physiological and pathological functions. Although significant information is already well-established about the role of Ca2+ in apoptosis, its role in autophagy has been recently determined and is poorly understood. Intracellular Ca2+ positively and negatively affects autophagy. In this review, evidence for both views and the interplay of Ca2+ between autophagy and apoptosis induction are discussed. The available data revealed the bidirectional role of Ca2+ in the regulation of autophagy. Moreover, the data also indicated that this role probably depends on the context of time, space, Ca2+ source, and cell state, thus either preventing or enhancing autophagy.

Keywords

Ca2+ IP3Rs Autophagic regulation Apoptosis Mitochondria 

Introduction

Autophagy is a main catabolic process of degrading and recycling intracellular components in lysosomes that cannot be executed by the ubiquitin–proteasome system. These components include long-lived proteins, damaged organelles, and some other macromolecules [1, 2]. Under well-fed conditions, autophagy in most cells is maintained at a low basal level, whereas under stressful conditions such as nutrition deprivation, high temperatures, oxidative stress, accumulation of damaged organelles, and cytosolic Ca2+ upload, autophagy is activated to play an essential role in sustaining cellular homeostasis and energy requirements, thus facilitating the survival of cells [3, 4]. Insufficient or altered autophagic flux is responsible for various diseases, such as cancer, neurodegenerative disorders, and cardiovascular disease, because of the significance of autophagy in cellular life and death processes [5, 6]. According to the manner of material delivery to the lysosomes, autophagy is divided into three main types, namely macroautophagy, chaperone-mediated autophagy, and microautophagy [7]. The former type is the most common form of autophagy (hereafter referred to as autophagy) and contains the formation and elongation of a typical double-membranous cistern (phagophores) into a whole vesicle (autophagosomes), which ultimately fuses with lysosomes to form autolysosomes, leading to the breakdown and recycling of the enclosed content [8].

The molecular basis of autophagy is complex. So far, more than 30 autophagy-related genes (ATGs) have been identified as crucial regulators of this complex process, from the initial signal to the final fusion [9, 10, 11]. In this family, one quite important member is Beclin 1, the mammalian ortholog of Atg6 in yeast; Beclin 1 plays a central role in the initial formation of autophagosome [12, 13]. Beclin 1 can dimerize and interact with Vps34, Vps15, Bif1, UVRAG, Ambra1, and some other proteins to generate phosphatidylinositol-3-phosphate (PI3P), which catalyzes vesicle elongation and phagophore nucleation by promoting the recruitment of other Atg proteins [14, 15]. Therefore, Beclin 1 depletion results in autophagic deficiency [16]. Remarkably, although the role of Beclin 1 in apoptosis has not been clearly elucidated, this ortholog has been determined as a member of the pro-apoptotic BH3-only protein family. Its BH3 domain mediates an interaction among anti-apoptotic Bcl-2 protein family members Bcl-2, Bcl-Xl, Mcl-1, and Bcl-w and thereby blocks the induction of the autophagic machinery under normal conditions [17, 18]. However, during autophagy-inducing conditions, Beclin 1 is allowed to dissociate from the Bcl-2–Beclin 1 protein complex and subsequently activates the PtdIns3K complex III to induce autophagy [19]. The interaction between Beclin 1 and Bcl-2 proteins can be dynamically regulated by various mechanisms. For instance, the phosphorylation of either Bcl-2 by c-Jun NH2-terminal kinase-1 or Beclin 1 by death-associated protein kinase (DAPK) antagonizes the interaction between the two proteins, and then, released Beclin 1 promotes autophagy [20, 21]. In addition, other proteins including BNIP3, nutrient-deprivation autophagy factor 1 (NAF-1), and high motility group box 1 (HMGB1) competitively disrupt the binding of Beclin 1 to Bcl-2 and regulate the onset of autophagy [22, 23, 24]. Furthermore, recent studies have shown that the suppression of Beclin 1’s function in autophagy is mainly attributed to Bcl-2 located at the endoplasmic reticulum (ER), with inhibitory effects on Ca2+-induced autophagy [25, 26, 27].

The network of stress signaling cascades and a number of protein complexes highlight significant considerations for autophagy regulation [28]. To date, the canonical and central sensor for the availability of energy and nutrients is the mammalian target of rapamycin (mTOR), in particular complex1 (mTORC1); mTOR functions as a negative regulator of autophagy [29, 30]. Although multiple signal pathways converge to modulate mTOR activity, one of the most important pathways is the AMP-activated protein kinase (AMPK), a positive regulator of autophagy [31]. Activated AMPK promotes the phosphorylation of the tuberous sclerosis complexes (TSC) 1 and 2. Subsequently, activation of TSC1/TSC2 suppresses mTOR activity by deactivating the mTORC1-interacting protein, Rheb, inducing autophagy [32, 33, 34]. In addition, AMPK can be phosphorylated and activated by Ca2+-calmodulin-dependent protein kinase kinase-β (CaMKKβ), which provides a close association among Ca2+ signaling, mTOR, and autophagy [35]. Indeed, recent studies have implicated the contributions of intracellular Ca2+ signaling and inositol 1,4,5-trisphosphate receptors (IP3Rs) to autophagy regulation; IP3Rs are tetrameric Ca2+ channels located at ER, and these channels release Ca2+ from the ER to the cytosol [36]. IP3Rs are major regulators of autophagy and apoptosis, which are also modulated by the members of the Bcl-2 family of proteins. The IP3Rs have been identified recently as a Bcl-2-regulated repressor of autophagy [37].

Ca2+, as a major intracellular second messenger, regulates multiple physiological functions in cells, such as contraction, secretion, metabolism, survival or death, and gene transcription. It also participates in some pathological processes [38, 39]. Previous studies showed that interference with calcium homeostasis can provoke cell death in many types of tumor cells [40]. A variety of cellular Ca2+-transporting and Ca2+-binding proteins are located mainly at the plasma, cytosol membrane, ER, and mitochondria, namely Ca2+ toolkit [41]. These correct spatiotemporal distributions of Ca2+ determine several of the most commonly recognized and well-studied intracellular signals [42, 43]. Although significant information is already well-established about the role of Ca2+ in apoptosis, the role of Ca2+ in autophagy regulation remains poorly understood. The role of Ca2+ signals involved in autophagy regulation was noted in the early 1990s, and the pioneering study already suggested a complicated role of Ca2+ as inhibitor and promoter of Ca2+ release from internal stores suppressed by autophagy [44]. In recent decades, a series of studies on the dual role of Ca2+ in autophagy regulation began to emerge, but their results still differ with respect to the precise mechanisms and pathways involved. On the one hand, numerous reports have revealed that Ca2+ functions as a negative regulator of autophagy [37, 45, 46, 47, 48, 49, 50]. On the other hand, other studies indicated a stimulatory role of Ca2+ toward autophagy [25, 51, 52, 53, 54, 55, 56]. The role of the ER as a physiologically important Ca2+ store is universally recognized, and IP3Rs may also have an important role in the control of autophagy, although the current data are at least partially contradictory [57, 58]. By releasing Ca2+ from the ER, these ubiquitously expressed channels control diverse cellular processes including cell proliferation and death. In addition, they play an essential role for a constitutive IP3R-mediated Ca2+ release to mitochondria in maintaining mitochondrial bioenergetics [48, 59, 60, 61].

In this study, the available evidence on the role of Ca2+ signal is summarized, in particular the IP3R-mediated Ca2+ release in the regulation of autophagy. Furthermore, the interplay of Ca2+ between autophagy and apoptosis induction is discussed. The available data not only showed a bidirectional role for Ca2+ in the control of autophagy but also suggested a model showing that this role may rely on the specific context, thus either preventing or enhancing autophagy.

Inhibition of autophagy by IP3R/Ca2+

An initial study indicating the inhibitory effect of IP3R on autophagy was based on the use of lithium (Li+). Li+-stimulated autophagic response, in turn, results in declined IP3 levels and diminishing Ca2+ release from the ER, which then triggers autophagy [45]. The study revealed a novel mTOR-independent manner that regulates autophagy. Criollo et al. subsequently confirmed IP3R in the control of autophagy [37]. They showed that chemical blockade with xestospongin B (XeB) or the silence of the IP3R with small interfering RNAs is a strong stimulus for the induction of autophagy in HeLa cells. They also reported an organelle-specific interaction between IP3R and Bcl-2 and proposed that IP3R may function as a Bcl-2-regulated inhibitor of autophagy, which specifically targeted the ER but not the mitochondria. However, ER stress-activated autophagy is not suppressed by Bcl-2, which implies a variety of signaling pathways involved in the regulation of autophagy. In view of the uncertain link between Ca2+ signaling and IP3R-modulated autophagy, the same laboratory proceeded to investigate and propose that IP3R-mediated Ca2+ release may not be an entitative part of the mechanism, whereas protein interactions with the channel may play a dominant role [46]. Thus, they presented evidence showing that IP3R may shut down autophagy by decreasing the release of Beclin 1 from Bcl-2-mediated sequestration, therefore facilitating the formation of anti-autophagic Bcl-2–Beclin 1 complexes. Moreover, xestospongin B or nutrient starvation would disrupt the interaction between the IP3R and Beclin 1 and thus release Beclin 1 available for the induction of autophagy. In this model, although autophagy negatively modulated by IP3R may be attributed to the obligate contribution of Beclin 1 instead of the involvement of the IP3R Ca2+ channel function, the IP3R was identified as an unsuspected regulator of the Beclin 1 complex and bridged an intriguing signal network that converges on the ER and initial phagophore formation.

The explicit mechanism of IP3R in autophagy regulation remains to be explored. Other studies did not confirm that the modulation of autophagy by the IP3R was independent of IP3-induced Ca2+ release. Glucocorticoids were shown to attenuate IP3-dependent calcium signaling and then induce autophagy by downregulating the src kinase Fyn, which is identified as a positive regulator of IP3-mediated calcium release by phosphorylating type I IP3 receptors (IP3R1) at Tyr353. Here, the induction of autophagy appeared to involve the canonical mTOR pathway [49]. Several groups investigated the role of IP3R using a unique IP3R-null cell line, DT40 chicken B cell lines, in which all three IP3R isoforms were genetically deleted (triple knockout (TKO) cells). Using this experimental model, Khan et al. observed a markedly elevated basal autophagic flux in TKO cells compared with wild-type cells even under nutrient-fertile conditions. They demonstrated that the Ca2+ channel function of the IP3R was essential for autophagy inhibition by IP3R. Furthermore, they documented that IP3R-mediated Ca2+ signals could regulate the autophagic pathway attributable to the inhibition of mTORC1 activity rather than correlated with AMPK, Akt, or Bcl-2–Beclin 1 complexes [47]. Similarly, Cardenas et al. reported higher levels of autophagic markers in TKO DT40 than their wild-type counterparts because of the absence of IP3R Ca2+ release activity; although in their study, they attributed this effect to reduced ATP production and the activation of AMPK but not mTOR [48]. By contrast, another study reported no evident difference between autophagy in wild-type and TKO DT40 cells presumably because of an adaptive alteration of the TKO DT40 cells and the expression of a truncated version of IP3R [46]. Although the basis for these discrepant results remains unknown, the existence of multiple regulatory mechanisms is not remarkable in the view of the complexity of the autophagic pathway and the differences in cell growth stage and stimuli.

A detailed explanation of the inhibitory effect of IP3R on autophagy induction was clarified by Foskett et al. [48], who reported the involvement of mitochondrial performance. This phenomenon is based on the presence of IP3Rs in ER domains, which are sensed by nearby mitochondria and permit the efficient transfer of Ca2+ from the ER to the mitochondria. This study showed that the impairment of IP3R-mediated Ca2+ release activity in TKO cells results in diminished Ca2+ uptake by the mitochondria. Subsequently, the diminished Ca2+ uptake results in decreased O2 consumption, reduced ATP production, and activation of AMPK, which indicate that mitochondrial oxidative phosphorylation was constitutively compromised. This compromise activates pro-survival autophagy even in nutrient-replete media. In addition, the researchers identified a molecular mechanism for autophagy regulation that involved non-canonical AMPK-dependent pathway because mTOR activation seemed to be unaltered. These observations suggest that constitutive IP3R-mediated Ca2+ release to the mitochondria is fundamentally essential for efficient mitochondrial respiration, maintenance of optimal cellular bioenergetics, and suppression of autophagy. Subsequent studies showed that the ER membrane protein Bax inhibitor-1 (BI-1) overexpression suppresses IP3R-dependent Ca2+ delivery from the ER to the mitochondria and thereby affects mitochondrial bioenergetics and facilitates autophagy [62]. The results identified BI-1 as a novel autophagy regulator that bridges Ca2+ signaling between the ER and the mitochondria through a mechanism that decreases cellular oxygen consumption and promotes AMPK activation. Consequently, this regulator contributes to cellular resilience in response to metabolic stress.

Autophagy induction can be mediated by L-type Ca2+ channel blockers, a K+ ATP channel opener, and Gi signaling activators, although they do not act directly on IP3R [50]. The latter data revealed an mTOR-independent pathway regulating autophagy, in which the established pathway from cyclic adenosine monophosphate (cAMP) to IP3 was identified as a strong negative regulator of autophagy by increasing intracytosolic Ca2+ levels and influencing calpain activity, indicative of a positive feedback loop of intracellular Ca2+ on autophagy inhibition. The IP3R-induced exit of Ca2+ from the ER leads to an increase in intracytosolic Ca2+, which is sufficient to activate the calcium-dependent cysteine protease calpains. Elevated LC3-labeled autophagosomes were observed after treatment with calpain inhibitors or transfection with siRNA of either calpain 1 or calpain 2. Similarly, Yuan et al. conducted a study using flurispirene, which is a compound that can block IP3-mediated Ca2+ release and activates autophagy [63]. Furthermore, these authors proposed a mechanism by which decreased intracellular Ca2+ prevents the calpain 1-mediated cleavage of Atg5, which, in turn, elevates the levels of the Atg5–Atg12 complex, necessary for the induction of autophagy. In agreement with the abovementioned studies, Mestre et al. showed that the deactivation of calpains by their inhibitor calpeptin could allow autophagy activation and revert cAMP inhibition of the autophagy induced by the toxin, thus confirming the negative effects on the autophagy regulation of calpains [64]. An overview of the inhibitory pathways described in this section is presented in Fig. 1.
Fig. 1

Ca2+ inhibits autophagy. On one hand, IP3R-mediated Ca2+ release toward the mitochondria results in increased ATP production and the suppression of AMPK and then inhibits autophagy. However, on the other hand, someone has attributed this phenomenon to the regulation of mTORC activity by Ca2+ instead of correlating with AMPK. Therefore, the inhibition or downregulation of IP3R with xestospongin B, siRNA, or in DT40 triple knockout (TKO) cells will promote autophagy. ER membrane protein Bax inhibitor-1 (BI-1) could suppress IP3R-dependent Ca2+ delivery from ER to mitochondria, thereby affecting mitochondrial bioenergetics and facilitating autophagy. IP3R might shut down autophagy by decreasing the release of Beclin 1 from Bcl-2-mediated sequestration, therefore facilitating the formation of anti-autophagic Bcl-2–Beclin 1 complexes. In addition, the IP3R-induced exit of Ca2+ from the ER is sufficient in activating calpains, which then cleave Atg5, leading to the inhibition of autophagy by decreasing the levels of the Atg5–Atg12 complex. This effect was shown to be well-regulated by the cAMP–Rap2B–PLCε pathway. Glucocorticoids induce autophagy by downregulating Fyn, which can promote IP3-mediated calcium release. Reducing IP3 levels through the addition of Li+, which inhibits IMPase, therefore induces autophagy

Induction of autophagy by Ca2+

In contrast to the inhibitory roles of IP3R/Ca2+ in autophagy regulation, numerous experimental conditions that consider Ca2+ as an activator of autophagy have also emerged in recent decades. However, the physiological relevance of many of these observations is ambiguous, and the precise mechanisms involved are always debatable. Hoyer-Hansen et al. provided a link among Ca2+ signaling, mTOR, and autophagy in detail [25]. They eventually demonstrated that elevated cytosolic calcium concentration ([Ca2+]c) by Ca2+-mobilizing agents functions as a potent trigger of autophagy through a mechanism that involves CaMKKβ, AMPK, and the subsequent suppression of mTOR signaling. This process could be inhibited by ER-located Bcl-2, which effectively lowers [Ca2+]ER and attenuates agonist-induced Ca2+ fluxes. Similarly, the latter data showed that the increase in [Ca2+]c by other pharmacological agents can also activate autophagy through the CaMKKβ–AMPK–mTOR pathway [56, 65], which has vital roles in diverse cellular processes including ribosome biogenesis and transcription in addition to metabolism and cell motility [66]. Furthermore, amyloid-β protein promotes the formation of autophagic vesicles also through the same CaMKKβ and AMPK signaling [67].

In addition to the “canonical” CaMKKβ–AMPK–mTOR pathway, Grotemeier et al. used an AMPK-independent pathway to account for Ca2+-activated autophagy. In their study, thapsigargin treatment, as a result of the elevation of cytosolic Ca2+, triggers autophagy in the absence of AMPK, with only minimal changes noted in mTOR activity. Thapsigargin, a non-competitive Ca2+ ATPase, can increase intracellular calcium by blocking the cell’s ability to pump calcium into the sarcoplasmic and endoplasmic reticula. The researchers further concluded that Ca2+ signaling triggering autophagy could be AMPK-dependent or AMPK-independent, and the inhibition of CaMKKβ reduces the level of thapsigargin-induced autophagy only in AMPK-positive cells [68]. Sakaki et al. showed another mechanism without inhibiting mTOR activity in thapsigargin-induced autophagy, but protein kinase C θ (PKCθ) activation followed by elevation in [Ca2+]c is specifically required for ER stress-induced autophagy, which could be blocked by the chelation of intracellular Ca2+ with BAPTA-AM [52]. In addition, another group demonstrated that Ca2+ release from the ER after cadmium treatment induces autophagy through the calcium–ERK pathway [53], although the targets of ERK were not clearly elucidated. Therefore, ERK may be associated with the phosphorylation of Bcl-2, thereby resulting in Beclin 1 release from Bcl-2 [69]. Following up on these studies, a recent investigation documented that CaMKI promotes the formation of autophagosomes through a pathway that involves PtdIns3K complex III instead of depending on AMPK (32). In this regard, Vps34, a component of the PtdIns3K complex III, is activated by calmodulin and Ca2+ [70].

Moreover, the overexpression of leucine-rich repeat kinase-2 (LRRK2) promotes the release of Ca2+ from lysosomal stores in human embryonic kidney cells, which, in turn, causes a persistent increase in autophagic vesicle formation through the Ca2+/CaMKKβ/AMPK pathway, but this effect of LRRK2 on autophagy induction is found to be mTORC1-independent [71]. In addition, LRRK2 overexpression upregulates the levels of SQSTM1/p62 in a Ca2+-dependent manner, which links ubiquitinated targets to the autophagic machinery [72]. Finally, a recent study inferred that quercetin could induce autophagy and is attributed to the elevated Ca2+, although the specific mechanisms of the calcium-signaling pathway in quercetin-induced autophagy remain to be revealed [73].

Recent studies exposed the presence of calcium microdomains mediated by different calcium channels situated at different cellular compartments, namely sarcolemma, mitochondria, sarcoplasmatic reticulum, and lysosome [74]. TRPML3, a Ca2+-permeable channel expressed in many intracellular compartments, including endosomes, lysosomes, and autophagosomes, is implicated in autophagy regulation. By specifically interacting with the mammalian Atg8 homolog GATE16, TRPML3 facilitates autophagosome maturation by providing Ca2+ in the fusion process [75]. Medina et al. showed that local calcineurin activation can occur in the vicinity of the lysosome through the lysosomal Ca2+ channel MCOLN1 and demonstrated that lysosomal Ca2+ signaling could induce autophagy by activating the phosphatase calcineurin and its substrate TFEB, which is a master transcription factor of lysosomal biogenesis and autophagy. They analyzed a Ca2+-dependent pathway that originates from the lysosome and modulates autophagy at the transcriptional level [76]. Furthermore, the knockdown or overexpression of the plasma membrane Ca2+ channel MCOLN3 can inhibit or activate autophagy, respectively. Remarkably, MCOLN3 is also recruited for autophagic vesicles upon the activation of autophagy, implying the important role of Ca2+ in autophagosome–lysosome fusion [77].

In addition to the treatment of Ca2+-mobilizing agents or the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA) inhibitors directly or indirectly leading to an elevated [Ca2+]c and subsequently stimulating autophagy, other autophagy inducers (such as starvation and rapamycin) may also result in autophagy stimulation through enhanced Ca2+ signaling, which could be blunted by the Ca2+ chelator BAPTA, as well as by the anti-apoptotic protein Bcl-2 [26]. Moreover, PK11195, an established chemosensitizer of tumor cells, functions as a facilitator of Ca2+-mediated autophagy by targeting the Bcl-2, which in its active form can decline [Ca2+]ER. Thus, PK11195 inhibits stimulus-induced Ca2+ release and Ca2+-mediated autophagy [78]. As Bcl-2 can inhibit IP3-mediated Ca2+ release, it may evoke dispute that IP3R sensitization by Beclin 1 is due to its effects on Bcl-2 by dissociating Bcl-2 from IP3Rs. However, a Beclin 1 mutant could sensitize IP3-induced Ca2+ release, even if it had failed to bind Bcl-2 [79], suggesting that these events were not only dependent on the suppression of the inhibitory effect of Bcl-2. Similarly, a recent study showed that an increased IP3R-mediated Ca2+ delivered from the ER and a sensitization of IP3R were observed in starved cells, which were required for starvation-induced autophagy. In this process, Beclin 1 was essential for IP3R sensitization, independent of its ability to bind Bcl-2 but rather due to its intrinsic property to bind IP3R [80]. A related study by Ghislat et al. demonstrated that starvation induces autophagy partly through elevated levels of cytosolic Ca2+ that activates the CaMKKβ–AMPK–mTOR pathway, subsequently resulting in ULK1 stimulation. ULK1 is a significant protein in autophagy and is a part of the ULK1 complex, which is necessary in the early stages of autophagosome biogenesis [81].

To date, although different mechanisms have already been proposed to account for Ca2+-mediated autophagy activation, this activation may be more complicated and depend on one or more of these mechanisms. Several other Ca2+-dependent targets are present in the regulation of autophagy, including the calmodulin-dependent DAPK, which positively regulates autophagy in several ways [82]. One way is the phosphorylation of Beclin 1 in its BH3 domain, which will finally promote the dissociation of Beclin 1 from Bcl-2/Bcl-xL-mediated sequestration [83]. Another approach is Ca2+ targets involved in autophagy activation that are the members of the S100 Ca2+-binding protein family, which include the S100B and S100A8/A9 complexes [84, 85]. S100B could interact with and then activate inositol monophosphatase (IMPase), which plays an important role in increasing IP3 production and subsequent Ca2+ release, constituting an amplification loop in the context of autophagy regulation. An overview of the stimulative pathways described in this section is presented in Fig. 2.
Fig. 2

Ca2+ induces autophagy. The cytosolic calcium concentration can be elevated by multiple factors, including Ca2+-mobilizing agents, the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA) inhibitors, or other autophagy inducers (such as starvation and rapamycin). These factors stimulate IP3R-mediated Ca2+ release from the ER. Stimulus-induced Ca2+ release could be blunted by the Ca2+ chelator, BAPTA, or Bcl-2. Increased cytosolic Ca2+ can trigger autophagy through various mechanisms; the activation of CaMKKβ by Ca2+ stimulates the AMPK-mediated suppression of mTOR signaling. The overexpression of LRRK2 promotes Ca2+ release from lysosomal stores and then initiates autophagy through the Ca2+/CaMKKβ/AMPK pathway, but this effect is mTOR-independent. Ca2+-activated autophagy can also be AMPK-independent. PKCθ activation followed by elevated Ca2+ is required for ER stress-induced autophagy. Ca2+-ERK pathway is also involved in autophagy induction, which may be associated with the phosphorylation of Bcl-2, thereby resulting in Beclin 1 release from Bcl-2. In addition, Ca2+ can activate DAPK, which phosphorylates Beclin 1, thereby mediating its dissociation from Bcl-2. Vps34 may also be activated by Ca2+, although this activation is still debated. Lysosomal Ca2+ signaling could also induce autophagy. TRPML3, a Ca2+-permeable channel mainly expressed in lysosomes, facilitates autophagosome maturation by providing Ca2+ in the fusion process through a specific interaction with Atg8. MCOLN1 and lysosomal Ca2+ channel could induce autophagy by activating the calcineurin and its substrate TFEB. Furthermore, the plasma membrane Ca2+ channel MCOLN3 also activates autophagy

Ca2+ connection in autophagy and apoptosis

Autophagy plays a protective role in maintaining cell survival during nutrient deprivation or other stressful situations, whereas cells undergo apoptosis when autophagy is suppressed [3, 86]. The inhibition of autophagy in HepG2 cells has pro-apoptotic effects, partly through enhanced ROS generation and activation of the mitochondrial apoptotic pathway, although the exact function of autophagy in apoptosis remains to be studied further [87]. Recent reports revealed that oxidative stress-triggered autophagic cell death is independent of apoptosis [87], suggesting that the processes of apoptosis and pro-survival autophagy are interrelated in a complicated manner or occur independently of each other. Therefore, the interplay between autophagy and apoptosis is controversial, and the scenario of autophagy in deciding cell destiny is elusive. At the molecular level, the cross talk between autophagy and apoptosis is beginning to emerge, and some autophagy-related and apoptosis-related proteins are identified as common regulators of both pathways, including the Beclin 1/Bcl-2 interaction. In addition, the tumor suppressor p53 is involved in autophagy regulation in addition to its pro-apoptotic effects [6]. Furthermore, many Atg proteins are caspase substrates, which gain pro-apoptotic functions through the cleaved C-terminal fragment of Beclin 1 [88, 89]. A similar switch from pro-autophagic to pro-apoptotic effects were represented on the calpain-mediated Atg5 cleavage [90], clearly indicating many potential links between these two pathways.

In particular, Ca2+ is a well-recognized regulator of multiple intracellular processes including apoptosis and autophagy. Therefore, the Ca2+ channel, IP3R, plays a crucial role [41]. Most of the compounds applied for Ca2+-mediated autophagy also promote apoptosis [25, 65, 78]. Thus, one might speculate that Ca2+ primarily activates apoptosis followed by the activation of autophagy [53]. However, this hypothesis is refuted by several data. The induction of autophagy occurs differently from apoptosis during cadmium treatment, and variations of Ca2+ concentration in cells seem to play a key role in regulating apoptosis and autophagy. This study demonstrated calcium-ERK-mediated autophagy and calcium-mitochondria-caspase-induced apoptosis [53], strongly suggesting that autophagy and apoptosis are Ca2+-dependent but go through different pathways. The differences between autophagy and apoptosis induction were also mentioned with regard to thapsigargin, ionomycin, and vitamin D3 [25]. However, different from cadmium-induced cytotoxicity, the induction of autophagy by quercetin manifests a protective effect by inhibiting apoptosis, attenuating lipid peroxidation, and recovering mitochondrial function [73]. Furthermore, recent evidence has shown that cells undergo autophagy instead of apoptosis if Bax/Bak is knocked out after hypericin-PDT treatment, which leads to ER Ca2+ depletion, although whether this phenomenon arises from the destruction of Ca2+ homeostasis or the subsequent ER stress was not investigated [51]. In addition, Lam et al. reported that Dictyostelium, an organism that cannot experience apoptosis, leads to autophagic cell death through IP3R, Ca2+ fluxes, and Ca2+-related protein [55].

Autophagy and apoptosis are related to the Ca2+ signal pathway. Therefore, confirming both outcomes during the particular treatment and reaching optimal conditions for the activation of autophagy but not for the induction of apoptosis are of great significance. The two outcomes are probably attributed to the different intracellular Ca2+ signals, which depend on the cellular location and the strength of the signal. Locally, cytosolic Ca2+ signals probably stimulate autophagy, whereas an elevated mitochondrial Ca2+ concentration can promote apoptosis [60]. In consideration of strength, Ca2+ oscillations may facilitate mitochondrial bioenergetics, but excessive Ca2+ transients in the mitochondria may result in permeabilization transition pore opening and subsequent mitochondrial outer membrane permeabilization.

Conclusions

The findings presented in this review provide novel insights into IP3R and Ca2+ in autophagy regulation in addition to their explicit participation in apoptosis. Nevertheless, the regulation of autophagy by Ca2+ is very plausible, and the exact mechanisms are still under debate. Stimulatory as well as inhibitory roles for Ca2+ toward autophagy have been proposed, depending on the cell state and reflecting different spatiotemporal Ca2+ signals in unstressed versus stressful situations. Under normal conditions, constitutive IP3R-mediated Ca2+ signals arise from the ER into the mitochondria for a certain level of ATP production. A high ATP/AMP ratio is sufficient in deactivating AMPK and therefore shutting down the induction of autophagy. The suppression of this signal leads to the activation of autophagy because of the aberrantly insufficient energy production. As a consequence, unstressed cells exhibit an autophagy restraining Ca2+ signal, which specifically targets mitochondria bioenergetics and underpins a crucial role for IP3R-induced Ca2+ release in the typical microdomains. However, when cells encounter stressful conditions, Ca2+ signaling is intensified, and an elevated Ca2+ level is required for autophagy induction. In this way, the downstream targets of Ca2+ may be cytosolic and not confined to a specialized microdomain. Although the exact pathway has not been completely understood, we can speculate that either CaMKKβ–AMPK–mTOR pathway or AMPK-independent way is involved. Generally, cells can switch their Ca2+ signal from an “unstressed” autophagy-suppressive and mitochondrial signal to a “stressful” autophagy-stimulative and cytosolic signal. Irrespective of the underlying mechanism, this bidirectional regulation of autophagy by the IP3R and Ca2+ plays an important role in determining cell fate. As autophagy is closely involved in pathological situations including cancer and neurodegenerative diseases, the correct understanding of the relationship between autophagy and Ca2+ dynamics may shed light on important therapeutic strategies.

Notes

Compliance with ethical standards

Conflicts of interest

None.

References

  1. 1.
    Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia-Arencibia M, Green-Thompson ZW, Jimenez-Sanchez M, Korolchuk VI, Lichtenberg M, Luo S, Massey DC, Menzies FM, Moreau K, Narayanan U, Renna M, Siddiqi FH, Underwood BR, Winslow AR, Rubinsztein DC. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev. 2010;90:1383–435.CrossRefPubMedGoogle Scholar
  2. 2.
    Knecht E, Aguado C, Carcel J, Esteban I, Esteve JM, Ghislat G, Moruno JF, Vidal JM, Saez R. Intracellular protein degradation in mammalian cells: recent developments. Cellular and molecular life sciences: CMLS. 2009;66:2427–43.CrossRefPubMedGoogle Scholar
  3. 3.
    Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T, Thompson CB. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell. 2005;120:237–48.CrossRefPubMedGoogle Scholar
  4. 4.
    Onodera J, Ohsumi Y. Autophagy is required for maintenance of amino acid levels and protein synthesis under nitrogen starvation. J Biol Chem. 2005;280:31582–6.CrossRefPubMedGoogle Scholar
  5. 5.
    Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132:27–42.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Wirawan E, Vanden Berghe T, Lippens S, Agostinis P, Vandenabeele P. Autophagy: for better or for worse. Cell Res. 2012;22:43–61.CrossRefPubMedGoogle Scholar
  7. 7.
    Mizushima N, Levine B. Autophagy in mammalian development and differentiation. Nat Cell Biol. 2010;12:823–30.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Singh R, Cuervo AM. Autophagy in the cellular energetic balance. Cell Metab. 2011;13:495–504.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Mizushima N, Yoshimori T, Ohsumi Y. The role of atg proteins in autophagosome formation. Annu Rev Cell Dev Biol. 2011;27:107–32.CrossRefPubMedGoogle Scholar
  10. 10.
    Rubinsztein DC, Shpilka T, Elazar Z. Mechanisms of autophagosome biogenesis. Current biology: CB. 2012;22:R29–34.CrossRefPubMedGoogle Scholar
  11. 11.
    Klionsky DJ, Cregg JM, Dunn Jr WA, Emr SD, Sakai Y, Sandoval IV, Sibirny A, Subramani S, Thumm M, Veenhuis M, Ohsumi Y. A unified nomenclature for yeast autophagy-related genes. Dev Cell. 2003;5:539–45.CrossRefPubMedGoogle Scholar
  12. 12.
    Cao Y, Klionsky DJ. Physiological functions of atg6/beclin 1: a unique autophagy-related protein. Cell Res. 2007;17:839–49.CrossRefPubMedGoogle Scholar
  13. 13.
    Yue Z, Jin S, Yang C, Levine AJ, Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A. 2003;100:15077–82.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Xie Z, Klionsky DJ. Autophagosome formation: core machinery and adaptations. Nat Cell Biol. 2007;9:1102–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Noble CG, Dong JM, Manser E, Song H. Bcl-xl and uvrag cause a monomer-dimer switch in beclin1. J Biol Chem. 2008;283:26274–82.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell. 2004;6:463–77.CrossRefPubMedGoogle Scholar
  17. 17.
    Ciechomska IA, Goemans GC, Skepper JN, Tolkovsky AM. Bcl-2 complexed with beclin-1 maintains full anti-apoptotic function. Oncogene. 2009;28:2128–41.CrossRefPubMedGoogle Scholar
  18. 18.
    Erlich S, Mizrachy L, Segev O, Lindenboim L, Zmira O, Adi-Harel S, Hirsch JA, Stein R, Pinkas-Kramarski R. Differential interactions between beclin 1 and bcl-2 family members. Autophagy. 2007;3:561–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Decuypere JP, Parys JB, Bultynck G. Regulation of the autophagic bcl-2/beclin 1 interaction. Cells. 2012;1:284–312.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Wei Y, Pattingre S, Sinha S, Bassik M, Levine B. Jnk1-mediated phosphorylation of bcl-2 regulates starvation-induced autophagy. Mol Cell. 2008;30:678–88.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Zalckvar E, Berissi H, Eisenstein M, Kimchi A. Phosphorylation of beclin 1 by dap-kinase promotes autophagy by weakening its interactions with bcl-2 and bcl-xl. Autophagy. 2009;5:720–2.CrossRefPubMedGoogle Scholar
  22. 22.
    Tang D, Kang R, Livesey KM, Cheh CW, Farkas A, Loughran P, Hoppe G, Bianchi ME, Tracey KJ, HJ 3rd Z, Lotze MT. Endogenous hmgb1 regulates autophagy. J Cell Biol. 2010;190:881–92.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Chang NC, Nguyen M, Germain M, Shore GC. Antagonism of beclin 1-dependent autophagy by bcl-2 at the endoplasmic reticulum requires naf-1. EMBO J. 2010;29:606–18.CrossRefPubMedGoogle Scholar
  24. 24.
    Bellot G, Garcia-Medina R, Gounon P, Chiche J, Roux D, Pouyssegur J, Mazure NM. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of bnip3 and bnip3l via their bh3 domains. Mol Cell Biol. 2009;29:2570–81.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Hoyer-Hansen M, Bastholm L, Szyniarowski P, Campanella M, Szabadkai G, Farkas T, Bianchi K, Fehrenbacher N, Elling F, Rizzuto R, Mathiasen IS, Jaattela M. Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-beta, and bcl-2. Mol Cell. 2007;25:193–205.CrossRefPubMedGoogle Scholar
  26. 26.
    Brady NR, Hamacher-Brady A, Yuan H, Gottlieb RA. The autophagic response to nutrient deprivation in the hl-1 cardiac myocyte is modulated by bcl-2 and sarco/endoplasmic reticulum calcium stores. The FEBS journal. 2007;274:3184–97.CrossRefPubMedGoogle Scholar
  27. 27.
    Marquez RT, Xu L. Bcl-2:beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch. Am J Cancer Res. 2012;2:214–21.PubMedPubMedCentralGoogle Scholar
  28. 28.
    Yang YP, Liang ZQ, Gu ZL, Qin ZH. Molecular mechanism and regulation of autophagy. Acta Pharmacol Sin. 2005;26:1421–34.CrossRefPubMedGoogle Scholar
  29. 29.
    Alers S, Loffler AS, Wesselborg S, Stork B. Role of ampk-mtor-ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol Cell Biol. 2012;32:2–11.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Jung CH, Ro SH, Cao J, Otto NM, Kim DH. Mtor regulation of autophagy. FEBS Lett. 2010;584:1287–95.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Hardie DG. Amp-activated/snf1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol. 2007;8:774–85.CrossRefPubMedGoogle Scholar
  32. 32.
    Inoki K, Zhu T, Guan KL. Tsc2 mediates cellular energy response to control cell growth and survival. Cell. 2003;115:577–90.CrossRefPubMedGoogle Scholar
  33. 33.
    Wang Z, Wilson WA, Fujino MA, Roach PJ. Antagonistic controls of autophagy and glycogen accumulation by snf1p, the yeast homolog of amp-activated protein kinase, and the cyclin-dependent kinase pho85p. Mol Cell Biol. 2001;21:5742–52.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Matsui Y, Takagi H, Qu X, Abdellatif M, Sakoda H, Asano T, Levine B, Sadoshima J. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of amp-activated protein kinase and beclin 1 in mediating autophagy. Circ Res. 2007;100:914–22.CrossRefPubMedGoogle Scholar
  35. 35.
    Witters LA, Kemp BE, Means AR. Chutes and ladders: the search for protein kinases that act on ampk. Trends Biochem Sci. 2006;31:13–6.CrossRefPubMedGoogle Scholar
  36. 36.
    Vicencio JM, Lavandero S, Szabadkai G. Ca2+, autophagy and protein degradation: thrown off balance in neurodegenerative disease. Cell Calcium. 2010;47:112–21.CrossRefPubMedGoogle Scholar
  37. 37.
    Criollo A, Maiuri MC, Tasdemir E, Vitale I, Fiebig AA, Andrews D, Molgo J, Diaz J, Lavandero S, Harper F, Pierron G, di Stefano D, Rizzuto R, Szabadkai G, Kroemer G. Regulation of autophagy by the inositol trisphosphate receptor. Cell Death Differ. 2007;14:1029–39.PubMedGoogle Scholar
  38. 38.
    Perez-Terzic CM, Chini EN, Shen SS, Dousa TP, Clapham DE. Ca2+ release triggered by nicotinate adenine dinucleotide phosphate in intact sea urchin eggs. The Biochemical journal. 1995;312(Pt 3):955–9.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol. 2003;4:517–29.CrossRefPubMedGoogle Scholar
  40. 40.
    Harr MW, Distelhorst CW. Apoptosis and autophagy: decoding calcium signals that mediate life or death. Cold Spring Harb Perspect Biol. 2010;2:a005579.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol. 2000;1:11–21.CrossRefPubMedGoogle Scholar
  42. 42.
    Hajnoczky G, Davies E, Madesh M. Calcium signaling and apoptosis. Biochem Biophys Res Commun. 2003;304:445–54.CrossRefPubMedGoogle Scholar
  43. 43.
    Pinton P, Giorgi C, Siviero R, Zecchini E, Rizzuto R. Calcium and apoptosis: Er-mitochondria ca2+ transfer in the control of apoptosis. Oncogene. 2008;27:6407–18.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Gordon PB, Holen I, Fosse M, Rotnes JS, Seglen PO. Dependence of hepatocytic autophagy on intracellularly sequestered calcium. J Biol Chem. 1993;268:26107–12.PubMedGoogle Scholar
  45. 45.
    Sarkar S, Floto RA, Berger Z, Imarisio S, Cordenier A, Pasco M, Cook LJ, Rubinsztein DC. Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol. 2005;170:1101–11.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Vicencio JM, Ortiz C, Criollo A, Jones AW, Kepp O, Galluzzi L, Joza N, Vitale I, Morselli E, Tailler M, Castedo M, Maiuri MC, Molgo J, Szabadkai G, Lavandero S, Kroemer G. The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with beclin 1. Cell Death Differ. 2009;16:1006–17.CrossRefPubMedGoogle Scholar
  47. 47.
    Khan MT, Joseph SK. Role of inositol trisphosphate receptors in autophagy in dt40 cells. J Biol Chem. 2010;285:16912–20.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Cardenas C, Miller RA, Smith I, Bui T, Molgo J, Muller M, Vais H, Cheung KH, Yang J, Parker I, Thompson CB, Birnbaum MJ, Hallows KR, Foskett JK. Essential regulation of cell bioenergetics by constitutive insp3 receptor ca2+ transfer to mitochondria. Cell. 2010;142:270–83.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Harr MW, McColl KS, Zhong F, Molitoris JK, Distelhorst CW. Glucocorticoids downregulate fyn and inhibit ip(3)-mediated calcium signaling to promote autophagy in t lymphocytes. Autophagy. 2010;6:912–21.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Williams A, Sarkar S, Cuddon P, Ttofi EK, Saiki S, Siddiqi FH, Jahreiss L, Fleming A, Pask D, Goldsmith P, O’Kane CJ, Floto RA, Rubinsztein DC. Novel targets for huntington’s disease in an mtor-independent autophagy pathway. Nat Chem Biol. 2008;4:295–305.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Buytaert E, Callewaert G, Hendrickx N, Scorrano L, Hartmann D, Missiaen L, Vandenheede JR, Heirman I, Grooten J, Agostinis P. Role of endoplasmic reticulum depletion and multidomain proapoptotic bax and bak proteins in shaping cell death after hypericin-mediated photodynamic therapy. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2006;20:756–8.Google Scholar
  52. 52.
    Sakaki K, Wu J, Kaufman RJ. Protein kinase ctheta is required for autophagy in response to stress in the endoplasmic reticulum. J Biol Chem. 2008;283:15370–80.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Wang SH, Shih YL, Ko WC, Wei YH, Shih CM. Cadmium-induced autophagy and apoptosis are mediated by a calcium signaling pathway. Cellular and molecular life sciences: CMLS. 2008;65:3640–52.CrossRefPubMedGoogle Scholar
  54. 54.
    Gao W, Ding WX, Stolz DB, Yin XM. Induction of macroautophagy by exogenously introduced calcium. Autophagy. 2008;4:754–61.CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Lam D, Kosta A, Luciani MF, Golstein P. The inositol 1,4,5-trisphosphate receptor is required to signal autophagic cell death. Mol Biol Cell. 2008;19:691–700.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Vingtdeux V, Giliberto L, Zhao H, Chandakkar P, Wu Q, Simon JE, Janle EM, Lobo J, Ferruzzi MG, Davies P, Marambaud P. Amp-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. J Biol Chem. 2010;285:9100–13.CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Decuypere JP, Bultynck G, Parys JB. A dual role for ca(2+) in autophagy regulation. Cell Calcium. 2011;50:242–50.CrossRefPubMedGoogle Scholar
  58. 58.
    Cardenas C, Foskett JK. Mitochondrial ca(2+) signals in autophagy. Cell Calcium. 2012;52:44–51.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Sammels E, Parys JB, Missiaen L, De Smedt H, Bultynck G. Intracellular ca2+ storage in health and disease: a dynamic equilibrium. Cell Calcium. 2010;47:297–314.CrossRefPubMedGoogle Scholar
  60. 60.
    Decuypere JP, Monaco G, Bultynck G, Missiaen L, De Smedt H, Parys JB. The ip(3) receptor-mitochondria connection in apoptosis and autophagy. Biochim Biophys Acta. 2011;1813:1003–13.CrossRefPubMedGoogle Scholar
  61. 61.
    Decuypere JP, Monaco G, Missiaen L, De Smedt H, Parys JB, Bultynck G. Ip(3) receptors, mitochondria, and ca signaling: implications for aging. Journal of aging research. 2011;2011:920178.CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Sano R, Hou YC, Hedvat M, Correa RG, Shu CW, Krajewska M, Diaz PW, Tamble CM, Quarato G, Gottlieb RA, Yamaguchi M, Nizet V, Dahl R, Thomas DD, Tait SW, Green DR, Fisher PB, Matsuzawa S, Reed JC. Endoplasmic reticulum protein bi-1 regulates ca(2)(+)-mediated bioenergetics to promote autophagy. Genes Dev. 2012;26:1041–54.CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Xia HG, Zhang L, Chen G, Zhang T, Liu J, Jin M, Ma X, Ma D, Yuan J. Control of basal autophagy by calpain1 mediated cleavage of atg5. Autophagy. 2010;6:61–6.CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Mestre MB, Colombo MI. Camp and epac are key players in the regulation of the signal transduction pathway involved in the alpha-hemolysin autophagic response. PLoS Pathog. 2012;8:e1002664.CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Law BY, Wang M, Ma DL, Al-Mousa F, Michelangeli F, Cheng SH, Ng MH, KF T, Mok AY, Ko RY, Lam SK, Chen F, Che CM, Chiu P, Ko BC. Alisol b, a novel inhibitor of the sarcoplasmic/endoplasmic reticulum ca(2+) atpase pump, induces autophagy, endoplasmic reticulum stress, and apoptosis. Mol Cancer Ther. 2010;9:718–30.CrossRefPubMedGoogle Scholar
  66. 66.
    Hay N, Sonenberg N. Upstream and downstream of mtor. Genes Dev. 2004;18:1926–45.CrossRefPubMedGoogle Scholar
  67. 67.
    Son SM, Jung ES, Shin HJ, Byun J, Mook-Jung I. Abeta-induced formation of autophagosomes is mediated by rage-camkkbeta-ampk signaling. Neurobiol Aging. 2012;33:1006 e1011–23.CrossRefGoogle Scholar
  68. 68.
    Grotemeier A, Alers S, Pfisterer SG, Paasch F, Daubrawa M, Dieterle A, Viollet B, Wesselborg S, Proikas-Cezanne T, Stork B. Ampk-independent induction of autophagy by cytosolic ca2+ increase. Cell Signal. 2010;22:914–25.CrossRefPubMedGoogle Scholar
  69. 69.
    Liu Y, Yang Y, Ye YC, Shi QF, Chai K, Tashiro S, Onodera S, Ikejima T. Activation of erk-p53 and erk-mediated phosphorylation of bcl-2 are involved in autophagic cell death induced by the c-met inhibitor su11274 in human lung cancer a549 cells. J Pharmacol Sci. 2012;118:423–32.CrossRefPubMedGoogle Scholar
  70. 70.
    Vergne I, Chua J, Deretic V. Tuberculosis toxin blocking phagosome maturation inhibits a novel ca2+/calmodulin-pi3k hvps34 cascade. J Exp Med. 2003;198:653–9.CrossRefPubMedPubMedCentralGoogle Scholar
  71. 71.
    Gomez-Suaga P, Luzon-Toro B, Churamani D, Zhang L, Bloor-Young D, Patel S, Woodman PG, Churchill GC, Hilfiker S. Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving naadp. Hum Mol Genet. 2012;21:511–25.CrossRefPubMedGoogle Scholar
  72. 72.
    Laurin N, Brown JP, Morissette J, Raymond V. Recurrent mutation of the gene encoding sequestosome 1 (sqstm1/p62) in Paget disease of bone. Am J Hum Genet. 2002;70:1582–8.CrossRefPubMedPubMedCentralGoogle Scholar
  73. 73.
    Cui X, Luo Y, Li C, Li Y, Wang Z. Changes of intracellular ca2+ in quercetin-induced autophagy progression. Acta Biochim Biophys Sin. 2015;47:908–14.CrossRefPubMedGoogle Scholar
  74. 74.
    Heineke J, Ritter O. Cardiomyocyte calcineurin signaling in subcellular domains: from the sarcolemma to the nucleus and beyond. J Mol Cell Cardiol. 2012;52:62–73.CrossRefPubMedGoogle Scholar
  75. 75.
    Choi S, Kim HJ. The ca2+ channel trpml3 specifically interacts with the mammalian atg8 homologue gate16 to regulate autophagy. Biochem Biophys Res Commun. 2014;443:56–61.CrossRefPubMedGoogle Scholar
  76. 76.
    Medina DL, Di Paola S, Peluso I, Armani A, De Stefani D, Venditti R, Montefusco S, Scotto-Rosato A, Prezioso C, Forrester A, Settembre C, Wang W, Gao Q, Xu H, Sandri M, Rizzuto R, De Matteis MA, Ballabio A. Lysosomal calcium signalling regulates autophagy through calcineurin and tfeb. Nat Cell Biol. 2015;17:288–99.CrossRefPubMedPubMedCentralGoogle Scholar
  77. 77.
    East DA, Campanella M. Ca2+ in quality control: an unresolved riddle critical to autophagy and mitophagy. Autophagy. 2013;9:1710–9.CrossRefPubMedGoogle Scholar
  78. 78.
    Gastaldello A, Callaghan H, Gami P, Campanella M. Ca 2+-dependent autophagy is enhanced by the pharmacological agent pk11195. Autophagy. 2010;6:607–13.CrossRefPubMedGoogle Scholar
  79. 79.
    Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, Packer M, Schneider MD, Levine B. Bcl-2 antiapoptotic proteins inhibit beclin 1-dependent autophagy. Cell. 2005;122:927–39.CrossRefPubMedGoogle Scholar
  80. 80.
    Decuypere JP, Welkenhuyzen K, Luyten T, Ponsaerts R, Dewaele M, Molgo J, Agostinis P, Missiaen L, De Smedt H, Parys JB, Bultynck G. Ins(1,4,5)p3 receptor-mediated ca2+ signaling and autophagy induction are interrelated. Autophagy. 2011;7:1472–89.CrossRefPubMedPubMedCentralGoogle Scholar
  81. 81.
    Ghislat G, Patron M, Rizzuto R, Knecht E. Withdrawal of essential amino acids increases autophagy by a pathway involving ca2+/calmodulin-dependent kinase kinase-beta (camkk-beta). J Biol Chem. 2012;287:38625–36.CrossRefPubMedPubMedCentralGoogle Scholar
  82. 82.
    Bialik S, Kimchi A. Lethal weapons: dap-kinase, autophagy and cell death: dap-kinase regulates autophagy. Curr Opin Cell Biol. 2010;22:199–205.CrossRefPubMedGoogle Scholar
  83. 83.
    Zalckvar E, Berissi H, Mizrachy L, Idelchuk Y, Koren I, Eisenstein M, Sabanay H, Pinkas-Kramarski R, Kimchi A. Dap-kinase-mediated phosphorylation on the bh3 domain of beclin 1 promotes dissociation of beclin 1 from bcl-xl and induction of autophagy. EMBO Rep. 2009;10:285–92.CrossRefPubMedPubMedCentralGoogle Scholar
  84. 84.
    Ghavami S, Eshragi M, Ande SR, Chazin WJ, Klonisch T, Halayko AJ, McNeill KD, Hashemi M, Kerkhoff C, Los M. S100a8/a9 induces autophagy and apoptosis via ros-mediated cross-talk between mitochondria and lysosomes that involves bnip3. Cell Res. 2010;20:314–31.CrossRefPubMedGoogle Scholar
  85. 85.
    Vig PJ, Shao Q, Subramony SH, Lopez ME, Safaya E. Bergmann glial s100b activates myo-inositol monophosphatase 1 and co-localizes to purkinje cell vacuoles in sca1 transgenic mice. Cerebellum. 2009;8:231–44.CrossRefPubMedPubMedCentralGoogle Scholar
  86. 86.
    Boya P, Gonzalez-Polo RA, Casares N, Perfettini JL, Dessen P, Larochette N, Metivier D, Meley D, Souquere S, Yoshimori T, Pierron G, Codogno P, Kroemer G. Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol. 2005;25:1025–40.CrossRefPubMedPubMedCentralGoogle Scholar
  87. 87.
    Xiong X, Wu M, Zhang H, Li J, Lu B, Guo Y, Zhou T, Guo H, Peng R, Li X, Tian Q, Wang Y. Atg5 sirna inhibits autophagy and enhances norcantharidin-induced apoptosis in hepatocellular carcinoma. Int J Oncol. 2015;47:1321–8.PubMedGoogle Scholar
  88. 88.
    Norman JM, Cohen GM, Bampton ET. The in vitro cleavage of the hatg proteins by cell death proteases. Autophagy. 2010;6:1042–56.CrossRefPubMedGoogle Scholar
  89. 89.
    Wirawan E, Vande Walle L, Kersse K, Cornelis S, Claerhout S, Vanoverberghe I, Roelandt R, De Rycke R, Verspurten J, Declercq W, Agostinis P, Vanden Berghe T, Lippens S, Vandenabeele P. Caspase-mediated cleavage of beclin-1 inactivates beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria. Cell Death Dis. 2010;1:e18.CrossRefPubMedPubMedCentralGoogle Scholar
  90. 90.
    Yousefi S, Perozzo R, Schmid I, Ziemiecki A, Schaffner T, Scapozza L, Brunner T, Simon HU. Calpain-mediated cleavage of atg5 switches autophagy to apoptosis. Nat Cell Biol. 2006;8:1124–32.CrossRefPubMedGoogle Scholar

Copyright information

© The Author(s) 2016

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors and Affiliations

  1. 1.Department of Clinical MedicineXuzhou Medical UniversityXuzhouChina
  2. 2.Department of Obstetrics and GynecologyXuzhou Hospital of Traditional Chinese MedicineXuzhouChina
  3. 3.Department of Obstetrics and GynecologyXuzhou Central HospitalXuzhouChina
  4. 4.Department of Obstetrics and GynecologyXuzhou Central HospitalXuzhouChina

Personalised recommendations